Similarly, IHC staining revealed a higher average H score (Methods) for FBLN5 in tumors from patients with advanced gastric cancer (AGC) (n = 7) compared with normal gastric tissues from non-cancer subjects (n = 3; P = 0.001) (Fig. 4d). This evidence concerns the gene FBLN5 and gastric cancer.